Company intelligence / Profile preview

Results RNA

Orem, Utah, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Results RNA is a biomedical research and product development company specializing in advanced intra-oral spray delivery systems for the healthcare and nutraceutical markets. The company utilizes its proprietary Advanced Cellular Technology (ACT) to create highly bioavailable formulations designed for detoxification, immune support, and cellular regeneration. Their flagship products, such as ACZ Nano and ACS 200, leverage nanotechnology to provide systemic support for heavy metal chelation and antimicrobial defense. Results RNA focuses on providing non-invasive, practitioner-grade solutions that emphasize rapid absorption and cellular-level efficacy.

Therapeutic areas: ImmunologyOtherNeurologyInfectious DiseasesRheumatologyMetabolic Disorders
Modalities: NanoparticleSmall molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on Results RNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Results RNA.

Explore the full profile